http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JO-2637-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
| filingDate | 2006-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c06f20732e73026369352b6ff26543d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61423554756279d38eb67244ec49d5c9 |
| publicationDate | 2012-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JO-2637-B1 |
| titleOfInvention | Use of different sulfamide derivatives combined with benzo ring in order to reduce lipids and reduce blood sugar levels |
| abstract | The present invention is a method for glucose-related and lipid-related diseases involving the intake of a patient in need of a therapeutically effective amount of the compound of formula (I) or formula (II) as specified herein. Diabetes, anti-lipid and anti-obesity factor. |
| priorityDate | 2005-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508054 |
Total number of triples: 13.